Commentary: an updated review of the published studies of homocysteine and cardiovascular disease.

Commentary: an updated review of the published studies of homocysteine and cardiovascular disease.

Dades bibliogràfiques
Autor principal:	Clarke, R
Format:	Journal article
Idioma:	English
Publicat:	2002

Ítems similars

Homocysteine and vascular disease: Review of published results of the homocysteine-lowering trials
per: Clarke, R, et al.
Publicat: (2011)

Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.
per: Clarke, R, et al.
Publicat: (2011)

Homocysteine and cardiovascular disease. Overview.
per: Clarke, R
Publicat: (1998)

Homocysteine, B vitamins, and the risk of cardiovascular disease.
per: Clarke, R
Publicat: (2011)

Homocysteine, renal function, and risk of cardiovascular disease.
per: Clarke, R, et al.
Publicat: (2003)

Homocysteine-lowering And Cardiovascular Disease: Is The Door Closing Now
per: Clarke, R
Publicat: (2009)

Homocysteine, B-vitamins, and the risk of cardiovascular disease.
per: Clarke, R, et al.
Publicat: (2005)

Homocysteine and risk of cardiovascular disease and venous thrombosis
per: Clarke, R, et al.
Publicat: (2003)

Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies.
per: Danesh, J, et al.
Publicat: (1998)

Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.
per: Den Heijer, M, et al.
Publicat: (2005)

Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.
per: Clarke, R, et al.
Publicat: (2001)

Homocysteine, B vitamins, and cardiovascular disease
per: Refsum, H, et al.
Publicat: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
per: Refsum, H, et al.
Publicat: (2006)

Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
per: Clarke, R, et al.
Publicat: (2007)

Homocysteine and coronary heart disease.
per: Clarke, R, et al.
Publicat: (2002)

Homocysteine, the kidney, and vascular disease.
per: Haynes, R, et al.
Publicat: (2012)

Homocysteine, the kidney, and vascular disease Moderate differences in homocysteine concentrations do not cause vascular disease
per: Haynes, R, et al.
Publicat: (2012)

Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
per: Clarke, R, et al.
Publicat: (2000)

Assessment of homocysteine as a cardiovascular risk factor in clinical practice.
per: Clarke, R, et al.
Publicat: (2001)

Detecting homocysteine in cardiovascular disease using aptasensors: A review
per: Sara Ranjbari, et al.
Publicat: (2023-12-01)

Homocysteine and prediction of coronary heart disease and stroke
per: Clarke, R, et al.
Publicat: (2003)

Homocysteine and cardiovascular risk: considering the evidence in the context of study design, folate fortification, and statistical power.
per: Ueland, P, et al.
Publicat: (2007)

Homocysteine-lowering trials for prevention of heart disease and stroke.
per: Clarke, R
Publicat: (2005)

Homocysteine, grey matter and cognitive function in adults with cardiovascular disease.
per: Andrew H Ford, et al.
Publicat: (2012-01-01)

HOMOCYSTEINE, LARGE ARTERIES AND CARDIOVASCULAR RISK
per: Jan Filipovský
Publicat: (2007-08-01)

Elevated plasma total homocysteine increased the risk of dementia in the elderly: Commentary
per: Sheehan, B, et al.
Publicat: (2002)

Citation of updated and co-published Cochrane Methodology Reviews
per: Linlin Zhu, et al.
Publicat: (2023-07-01)

Homocysteine and Folic Acid: Risk Factors for Alzheimer's Disease—An Updated Meta-Analysis
per: Qianwen Wang, et al.
Publicat: (2021-05-01)

Role of Homocysteine in Diseases: A Review
per: Maryam Moradi Binabaj, et al.
Publicat: (2016-09-01)

Homocysteine, B vitamins, and the risk of dementia.
per: Clarke, R
Publicat: (2007)

Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
per: Clarke, R, et al.
Publicat: (1998)

Homocysteine levels and risk of essential hypertension: A meta-analysis of published epidemiological studies
per: Fade Zhong, et al.
Publicat: (2017-02-01)

The Impact of Cardiovascular Disease Gene Polymorphism and Interaction with Homocysteine on Deep Vein Thrombosis
per: Lei-Lei Niu, et al.
Publicat: (2024-09-01)

Cardiovascular disease among patients with type 2 diabetes: role of homocysteine as an inflammatory marker
per: Ashok Sahu, et al.
Publicat: (2016-04-01)

Homocysteine And Neurological Disease
per: Nagaraja D
Publicat: (2004-01-01)

Broken instrument may incidentally be found in second surgery: Update and commentary on a previously published article
per: Ganesh Singh Dharmshaktu, et al.
Publicat: (2021-01-01)

The hordaland homocysteine study: A community-based study of homocysteine, its determinants, and associations with disease
per: Refsum, H, et al.
Publicat: (2006)

Therapeutical approach to plasma homocysteine and cardiovascular risk reduction
per: Marcello Ciaccio, et al.
Publicat: (2008-03-01)

Features of Plasma Homocysteine, Vitamin B12, and Folate in Parkinson's Disease: An Updated Meta-Analysis
per: Yiti Liu, et al.
Publicat: (2023-08-01)

A Review of Psoriasis, a Known Risk Factor for Cardiovascular Disease and Its Impact on Folate and Homocysteine Metabolism
per: Ian McDonald, et al.
Publicat: (2012-01-01)